Literature DB >> 14517183

Mechanisms of relaxation by urocortin in renal arteries from male and female rats.

Elena Sanz1, Luis Monge, Nuria Fernández, Belén Climent, Godofredo Diéguez, Angel Luis Garcia-Villalón.   

Abstract

Urocortin is a peptide recently identified, which is structurally related to the corticotropin-releasing factor (CRF). To analyze the mechanisms that could be involved in its effect on renal arteries from male and female rats, the response to urocortin was studied in isolated segments, 2 mm long, of renal arteries from male and female rats. In renal artery segments precontracted with endothelin-1 (1 nm), urocortin (1 pm-10 nm) produced concentration-dependent relaxation, which was similar in the arteries from male and female rats. This relaxation was reduced by the antagonists of urocortin receptors astressin (1 microM) and alpha-helical CRF(9-41) (1 microM) in arteries from both male and female rats. In renal arteries from female rats, the relaxation to urocortin was reduced by the inhibitor of adenyl cyclase SQ22536 (300 microM), by 8-bromo-cyclic-ADP-ribose (cADPR; 30 microM), an antagonist of the endogenous activator of sarcoplasmic Ca2+ channel cADPR and by ryanodine (1 microM), which produces depletion of sarcoplasmic Ca2+. In renal arteries from male rats, the relaxation to urocortin was increased by ryanodine, and was not modified by SQ22536 or 8-bromo-cADPR. These results suggest that the mechanisms involved in the relaxation to urocortin in renal arteries differ between female and male rats. In female rats, this relaxation may be mediated by the production of cyclic AMP (cAMP), synthesis of cADPR and release of sarcoplasmic Ca2+, whereas in male rats it is not mediated by cAMP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517183      PMCID: PMC1574106          DOI: 10.1038/sj.bjp.0705516

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Vasodilation by the calcium-mobilizing messenger cyclic ADP-ribose.

Authors:  François-Xavier Boittin; Michelle Dipp; Nicholas P Kinnear; Antony Galione; A Mark Evans
Journal:  J Biol Chem       Date:  2002-12-16       Impact factor: 5.157

Review 2.  The pharmacology of ryanodine and related compounds.

Authors:  J L Sutko; J A Airey; W Welch; L Ruest
Journal:  Pharmacol Rev       Date:  1997-03       Impact factor: 25.468

3.  Structural determination of a cyclic metabolite of NAD+ with intracellular Ca2+-mobilizing activity.

Authors:  H C Lee; T F Walseth; G T Bratt; R N Hayes; D L Clapper
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

4.  The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings.

Authors:  N Satake; M Shibata; S Shibata
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Modulation of coronary smooth muscle KCa channels by Gs alpha independent of phosphorylation by protein kinase A.

Authors:  F S Scornik; J Codina; L Birnbaumer; L Toro
Journal:  Am J Physiol       Date:  1993-10

6.  Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart.

Authors:  K Terui; A Higashiyama; N Horiba; K I Furukawa; S Motomura; T Suda
Journal:  J Endocrinol       Date:  2001-04       Impact factor: 4.286

7.  Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas.

Authors:  J Sadoshima; N Akaike; H Kanaide; M Nakamura
Journal:  Am J Physiol       Date:  1988-10

8.  Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation.

Authors:  H Kume; A Takai; H Tokuno; T Tomita
Journal:  Nature       Date:  1989-09-14       Impact factor: 49.962

9.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.

Authors:  J Vaughan; C Donaldson; J Bittencourt; M H Perrin; K Lewis; S Sutton; R Chan; A V Turnbull; D Lovejoy; C Rivier
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

10.  Studies on the phosphorylation of myelin basic protein by protein kinase C and adenosine 3':5'-monophosphate-dependent protein kinase.

Authors:  A Kishimoto; K Nishiyama; H Nakanishi; Y Uratsuji; H Nomura; Y Takeyama; Y Nishizuka
Journal:  J Biol Chem       Date:  1985-10-15       Impact factor: 5.157

View more
  4 in total

1.  [Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia].

Authors:  H Tezval; A S Merseburger; M Seidler; J Serth; M A Kuczyk; M Oelke
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

2.  Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.

Authors:  Pin-Lan Li; Yang Zhang; Justine M Abais; Joseph K Ritter; Fan Zhang
Journal:  Messenger (Los Angel)       Date:  2013-06-01

Review 3.  The Role of Urocortins in Intracerebral Hemorrhage.

Authors:  Ker Woon Choy; Andy Po-Yi Tsai; Peter Bor-Chian Lin; Meng-Yu Wu; Chihyi Lee; Aspalilah Alias; Cheng-Yoong Pang; Hock-Kean Liew
Journal:  Biomolecules       Date:  2020-01-07

4.  Type 2β Corticotrophin Releasing Factor Receptor Forms a Heteromeric Complex With Dopamine D1 Receptor in Living Cells.

Authors:  Hector E Yarur; Maria Estela Andrés; Katia Gysling
Journal:  Front Pharmacol       Date:  2020-01-08       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.